7/1/2026 Categories: Industries Angelini Industries: total revenues reach €1.7 billion (+4.6%). Growth in pharmaceuticals and industrial technology
5/8/2026 Categories: Pharma Angelini Pharma to acquire Catalyst Pharmaceuticals, entering the U.S. Market and consolidating its leadership in Brain Health and Rare Disease
5/11/2023 Categories: Health Angelini Pharma and JCR Pharmaceuticals Announce Global Collaboration for the Development and Commercialization of Novel Biologic Therapies in Epilepsy
11/21/2022 Categories: Pharma Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma
9/29/2022 Categories: Pharma New Headway Report highlights environmental determinants of mental health
Angelini Industries
